Patent intelligence · IS
IS 5505
Notkun á blöndu díóls og alfa-hýdroxýsýru til að meðhöndla sjúkdóma sem lýsa sér í ofvexti í hornlagi húðþekju
Notkun á blöndu díóls og alfa-hýdroxýsýru til að meðhöndla sjúkdóma sem lýsa sér í ofvexti í hornlagi húðþekju
Patent details — IS 5505
- Jurisdiction
- IS
- Status
- expired
- Grant date
- May 23, 2000
- Expiration
- May 18, 2020
- Applicant
- ASTELLAS PHARMA EUROP B V [NL]
- CPC classes
- A61K 9/ 00 A I, A61K 9/ 06 A I, A61K 31/ 19 A I, A61K 47/ 00 A I
Quick answer
IS 5505 (Notkun á blöndu díóls og alfa-hýdroxýsýru til að meðhöndla sjúkdóma sem lýsa sér í ofvexti í hornlagi húðþekju) is held by ASTELLAS PHARMA EUROP B V [NL]. Status: expired. Granted May 23, 2000. Expires May 18, 2020 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- ASTELLAS PHARMA EUROP B V [NL]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 9/ 00 A I, A61K 9/ 06 A I, A61K 31/ 19 A I, A61K 47/ 00 A I, A61K/3119, A61K/90014
More from ASTELLAS PHARMA EUROP B V [NL]
Related pharmaceutical patents in our USPTO index.
-
CN 120418289
Combination therapy of bispecific binding agents that bind to CLDN18.2 and CD3 with immune checkpoint inhibitors
granted -
KR 20240032847
CLDN18.2 및 CD3에 결합하는 이중특이 결합제
granted -
CN 105120840
Composition of tiacumicin compounds
granted -
EP 1549658
VERBINDUNGEN AUF GLUKOSEBASIS MIT AFFINITÜT FÜR P-SELEKTIN
expired -
EP 1527086
VERBINDUNGEN DIE P-SELECTIN BINDEN
expired -
EP 1423413
SELEKTIV P-SELECTIN BINDENDE PEPTIDISCHE VERBINDUNGEN
expired -
EP 1392755
ZUSAMMENSETZUNGEN ENTHALTEND LIPID-POLYMER KONJUGATE
expired
Frequently asked questions
What is US patent 5505?
IS 5505 (Notkun á blöndu díóls og alfa-hýdroxýsýru til að meðhöndla sjúkdóma sem lýsa sér í ofvexti í hornlagi húðþekju) is held by ASTELLAS PHARMA EUROP B V [NL]. Status: expired. Granted May 23, 2000. Expires May 18, 2020 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns IS 5505?
ASTELLAS PHARMA EUROP B V [NL] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 10 pharmaceutical patents for this assignee.
When does IS 5505 expire?
Our index shows an expiration date of May 18, 2020 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.